In our presentation today ... We continue to believe that it is important to evaluate Evercore's performance on an annual basis. As we've noted previously, our results for any particular quarter ...
Shares of Vera Therapeutics (VERA) sold off about 20% on Friday following news in competitor Otsuka’s 2024 earnings presentation that the ...
Evercore ISI analyst Chris McNally maintained a Buy rating on QuantumScape (QS – Research Report) yesterday and set a price target of $10.00. The company’s shares closed yesterday at $5.17 ...
15d
Evercore Inc. (NYSE: EVR) today announced its results for the fourth quarter and full year ended December 31, 2024. LEADERSHIP COMMENTARY John S. Weinberg, Chairman and Chief Executive Officer, "We ...
In our presentation today ... We continue to believe that it is important to evaluate Evercore's performance on an annual basis. As we have noted previously, our results for any particular ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback